Evaluating the Clinical Utility of the Glycemia Risk Index

The GRI is perceived as a valuable complement to traditional CGM reports, particularly in facilitating quick clinical assessments and furthering diabetes care and education. While enthusiasm for broader integration is high, barriers such as lack of standardization, limited guideline adoption, and HCP training must be addressed to support its clinical uptake. Future work should assess the GRI's impact on clinical outcomes and explore implementation strategies.